MARKET

SRPT

SRPT

Sarepta Therapeutics Inc
NASDAQ
16.02
-0.68
-4.04%
Pre Market: 15.89 -0.13 -0.81% 07:59 06/26 EDT
OPEN
16.73
PREV CLOSE
16.70
HIGH
16.85
LOW
15.94
VOLUME
887
TURNOVER
0
52 WEEK HIGH
25.32
52 WEEK LOW
10.42
MARKET CAP
1.69B
P/E (TTM)
147.51
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SRPT last week (0615-0619)?
Weekly Report · 4d ago
Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), Eli Lilly & Co (LLY) and C4 Therapeutics (CCCC)
TipRanks · 4d ago
Barclays Sticks to Its Hold Rating for Sarepta Therapeutics (SRPT)
TipRanks · 4d ago
Sarepta Therapeutics (SRPT) Stock Could Be 19% Undervalued As Elevidys Outlook Steadies
Simply Wall St · 4d ago
Is Sarepta (SRPT) Quietly Recasting Its Story Around siRNA as Elevidys Awaits Regulators?
Simply Wall St · 6d ago
Sarepta: Caution Still Warranted Despite FDA's Gene Therapy-Friendly Stance
Seeking Alpha · 06/18 13:48
Analysts Offer Insights on Healthcare Companies: Owlet (OWLT), Praxis Precision Medicines (PRAX) and Sarepta Therapeutics (SRPT)
TipRanks · 06/18 11:41
Small Caps Near Record Highs, Robinhood Rallies 12%: Stock Market Today
Benzinga · 06/17 17:33
More
About SRPT
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, siRNA knockdown therapies, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. It has developed multiple approved products for the treatment of Duchenne muscular dystrophy (Duchenne) and is developing potential therapeutic candidates for a range of diseases and disorders, including Duchenne, Limb-girdle muscular dystrophies (LGMDs) and other neuromuscular and central nervous system (CNS) related disorders. The Company has developed and commercialized four approved products for the treatment of Duchenne: EXONDYS 51 (eteplirsen), Injection (EXONDYS 51), VYONDYS 53 (golodirsen) Injection (VYONDYS 53), AMONDYS 45 (casimersen) Injection (AMONDYS 45), and ELEVIDYS.

Webull offers Sarepta Therapeutics Inc stock information, including NASDAQ: SRPT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRPT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SRPT stock methods without spending real money on the virtual paper trading platform.